Showing results (41-50 of 686) with videos related to
Sort By:
Pageof 69
Expert Opinion on Pharmacotherapy|November 12, 2013
Summarizing the FIELD study: lessons from a 'negative' trialVasilis Tsimihodimos, Dimitri P Mikhailidis, Moses ElisafCurrent Pharmaceutical Design|July 12, 2016
Lipids, Statins and Heart Failure: An UpdateNiki Katsiki, Michael Doumas, Dimitri P MikhailidisClinical Nutrition (Edinburgh, Scotland)|September 15, 2020
Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based studyMohsen Mazidi, Dimitri P Mikhailidis, Maciej BanachCurrent Pharmaceutical Design|June 24, 2014
Alcohol and the cardiovascular system: a double-edged swordNiki Katsiki, Konstantinos Tziomalos, Dimitri P MikhailidisExpert Opinion on Investigational Drugs|November 26, 2010
Dapagliflozin: more than just another oral glucose-lowering agent?Niki Katsiki, Nikolaos Papanas, Dimitri P MikhailidisCurrent Medical Research and Opinion|September 17, 2010
Ezetimibe in diabetes: more than cholesterol lowering?Maria Sarigianni, Niki Katsiki, Dimitri P MikhailidisExpert Opinion on Pharmacotherapy|July 26, 2019
Lipid-lowering agents for concurrent cardiovascular and chronic kidney diseaseNiki Katsiki, Dimitri P Mikhailidis, Maciej BanachCurrent Medical Research and Opinion|November 5, 2003
Early vascular benefits of statin therapyStavroula Tsiara, Moses Elisaf, Dimitri P MikhailidisAngiology|February 21, 2003
Apolipoprotein E polymorphism and atherosclerosisGenovefa Kolovou, Deliana Daskalova, Dimitri P MikhailidisExpert Opinion on Pharmacotherapy|December 14, 2011
Metformin and heart failure: never say never againNikolaos Papanas, Efstratios Maltezos, Dimitri P MikhailidisPageof 69